Alzheimer's & Dementia
Experience with donanemab over a 1-year period: observations of side effects and compliance from a regional specialty medical center
Study in peopleInterventions
Neurology4 Oct 2026

Annals of Neurology4 Oct 2026

medRxiv4 Oct 2026
Research Square4 Oct 2026
